Psyrri A, Boutati E, Karageorgopoulou S; Anti-Cancer Drugs (Mar 2011) Human papillomaviruses (HPVs), especially type 16, are implicated in the development of a subset of head and neck squamous cell cancers (HNSCCs). This subset of oropharyngeal cancers possesses distinct clinical and laboratory features and outcome, and is particularly common in individuals who lack the traditional […]
Gardasil: Fear or Facts?
Hudsonspinalhealth
Fear or Facts? On which will you base your decision to vaccinate? While we will not try to convince anyone to get vaccinated or decline vaccination, we do encourage making an educated decision and to NEVER make a major decision out of fear. One of the most disturbing cases of fear-mongering is that which revolves around the Gardasil vaccination. The Gardasil vaccine is targeted to females ages 9-26 in hopes of”preventing” cervical cancer.
Here are some facts you need to know about HPV:
* When detected in the early stages, the HPV virus is easily treated and rarely proceeds to cancer.
* Not all women with HPV develop cervical cancer.
* HPV is just one of several potential causes of cervical cancer.
* At least 50% of sexually active men and women acquire genital HPV infection at some point in their lives — and 90% of the time the virus clears up on its own within two years, and does not lead to cancer.
Birth Control, HPV and Cervical Cancer
By Salynn Boyles Long-term use of birth control pills appears to increase the risk of developing cervical cancer in women who have HPV, but experts say the risk is eliminated with careful screening. Cervical cancer risk in women who used birth control pills for a decade or more was double that of women who had […]
Green Tea, HPV and Cervical Cancer
Cervical Cancer kills thousands worldwide every year. HPV is a leading cause of cervical cancer. Researchers have discovered that chemicals in green tea are able to suppress the growth of HPV-caused cervical cancer cells. Mar 09, 2011 – The latest statistics of the World Health Organization (WHO) suggest that over 288,000 women die every year […]
Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV
BLUE BELL, Pa., Mar. 7, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus (HPV). […]
- « Previous Page
- 1
- …
- 16
- 17
- 18
- 19
- 20
- …
- 54
- Next Page »
